Diabetes

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity. Read More

Howard Baum, M.D., assistant professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, has been elected vice president (physician-in-practice) of The Endocrine Society. Read More

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment. Read More

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes. Read More

In the latest VUCast: Learn how researchers behind a life-saving social media campaign are promising #WeWillNotGiveUp; find out how your brain "sees" in the dark; and hear about the No. 1 ranking that's making Vanderbilt students happy. Watch now! Read More

A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research. Read More

A group of adolescents gathered at the downtown Nashville Public Library last week for a three-day Digital Storytelling Workshop to learn how to write, edit and produce a video about managing their type 1 diabetes. Read More

Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets. Read More

Underserved patients with sub-optimally controlled type 2 diabetes who were cared for by pharmacists were more adherent to their medication regimen and had better blood sugar control than those who did not have a pharmacist in their care team. Read More

New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas. Read More

Vanderbilt University researchers have created a zebrafish model of skeletal muscle insulin resistance that could help improve diabetes treatment. Read More

New findings explain why variation in a particular gene is the most important determinant of fasting blood glucose levels in humans. Read More

Vanderbilt Diabetes Day, an annual research symposium, this year featured talks by nationally known researchers and by winners of the Diabetes Scholar awards. Read More

Vanderbilt University is part of a national effort to improve diabetes treatment by developing strategies for proliferating, regenerating and improving the function of insulin-producing beta cells in the pancreatic islets. Read More

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read More

Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure. Read More

Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. Read More

The protein CaMKII acts as a calcium sensor in a positive feedback pathway that enhances glucose-stimulated insulin secretion. Read More

The extracellular matrix that surrounds cells plays a role in the development of insulin resistance. Read More

Knowing when to take a medication — and what to do if a dose is missed — could greatly improve adherence to diabetes medications and glycemic control among adults with type 2 diabetes, according to a Vanderbilt study published in the journal Diabetes Care. Read More